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Human thrombin is inactivated by l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) or I-ethyl-3-(4axonia-4,4& 
methyl~ntyl~r~dii~de (EAC) by a second order process. A plot of the pseudo-first order rate constant for inactiva- 
tion by 20 mM EDC at different pH values from 4.2 to 7.7 at 25°C shows that this inactivation is due to the modification 
of a protona~ carboxyl with a p& of 5.6. The rate of inactivation by EDC at pH 6.0 is reduced, but not eliminated 
by saturating levels of the competitive inhibitor dansyl-L-arginine IV-(3-ethyl-1,5pentanediyl)amide, suggesting that the 
essential carboxyl modified is one other than Asp-189 in the substrate specificity pocket of t~ombin. Complete inactiva- 
tion by ‘+C-EAC correlates with the incorporation of approximately 2.5-3 EACs per thrombin. 
Thrombin; Carboxyl, essential; Carbodiimide; EDC; EAC; DAPA 
1. INTRODUCTION 
Several studies [ 1,2] have suggested that carbox- 
yl groups play a critical role in the catalytic func- 
tion of thrombin, a serine protease with trypsin- 
like specificity 131. The amino acid sequences of 
bovine [4] and human [5] thrombins have been 
determined, and the results show that the enzyme 
has high sequence homology with trypsin and 
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Abbreviations: EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbo- 
diimide hydrochloride; EAC, l-ethyl-3-(4axonia-4,4-dimethyl- 
pentylkzarboiimide iodide; DAPA, dansyl-L-arginine N-(3- 
ethyl-l ,5pentanediyl)-amide; Mes, 2-(N-morpholino)ethane- 
sulfonic acid, Hepes, ~-2-hydroxyethylpipera~ne-~I-2-ethane- 
sulfonic acid; S-2238, tosyl-D-phenylalanyl-D-pipecolyl-L-ar- 
ginine-~nitroa~de; k ‘, the pseudo-first order rate constant 
for inactivation of thrombin by ECD or EAC under a given set 
of conditions; KTC,, the DAPA concentration at which thrombin 
is half-saturated 
Additionalfootnote: Thrombin residues are numbered using the 
numbering system for bovine chymotrypsin. 
chymotrypsin. Asp-189 is conserved in thrombin, 
when compared to trypsin, and this carboxylate 
likely plays the role of a negatively charged 
recognition site in the substrate specificity pocket. 
Furie et al. [6], based on a computer-generated 
model of t~ombin derived from X-ray crystallo- 
graphic data on trypsin and chymotrypsin, suggest 
that 3 other carboxyls which have no counterpa~ in 
trypsin may also be near the catalytic center. 
We have previously shown, using inactivation 
with ECD, that bovine thrombin has a critical car- 
boxy1 group with a p& of 5.5 121. We report herein 
similar data for human thrombin, plus stoichio- 
metry of inactivation of the human enzyme by 
[14C]EAC. In addition, we show that while both 
human and bovine thrombin show significant pro- 
tection against inactivation in the presence of 
DAPA, a potent competitive inhibitor, the DAPA- 
saturated enzymes are still inactivated by EDC at a 
significant rate. This suggests that the essential car- 
boxy1 group modified by water-soluble carbodi- 
imides may be one other than Asp-189. A 
preliminary account of some of this work has ap- 
peared [7]. 
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2. MATERIALS AND METHODS 
Human thrombin was a generous gift from Dr F.C. Church. 
It had been prepared by the method of Church and Whinna [8] 
and was stored frozen in 20 mM Hepes, 750 mM NaCl, 3 mM 
NaN3, 0.1% (w/v) PEG, pH 6.5, until use. [‘4C]CHsI 
(50 mCi/mmol) and Ecolume scintillation fluid were purchased 
from ICN Radiochemicals, Irvine, CA. EDC and buffer salts 
were obtained from Sigma Chemical Company, St. Louis, MO, 
while S-2238, a product of Kabi Vitrum, Stockholm, Sweden, 
was purchased from Helena Laboratories, Beaumont, TX. 
DAPA was a gift from Dr S.T. Olson. EAC ([r4C]EAC, 
2-2.5 mCi/mmol) was synthesized from EDC and CHsI ([r4C]- 
CHsI) as described elsewhere [S]. 
Thrombin activity was measured as previously described [2], 
except that the final concentration of S-2238 in the 1.00 ml 
assay solution was 50 PM instead of 100 pM. The concentration 
of human thrombin was determined at neutral pH from A280 = 
1.75 for a 1 mg/ml solution and a molecular mass of 36 600 Da 
[lo]. Chemical modifications of thrombin, where the activity 
was followed as a function of time, were carried out at 25°C as 
described in the figure legends. The activity is expressed as V, 
the activity of the modified enzyme, divided by I’,, the activity 
of the appropriate control, multiplied by 100. The activities of 
the controls were stable for the duration of the experiments at 
pH 5.9 and above, but were found to decrease with time at lower 
pH values. 
For the correlation of inactivation of human thrombin with 
incorporation of [r4C]EAC, the enzyme (0.6 mg/ml) was in- 
cubated at 25°C with 4 mM [14C]EAC, in 75 mM Mes, 25 mM 
Hepes, pH 6.0, for 25,45, or 85 min before a 1 .O ml aliquot was 
passed over a Biogel P-6 column (0.9 x 38 cm) equilibrated with 
25 mM sodium phosphate, 100 mM NaCl, pH 6.0, to separate 
the modified thrombin from the free [14C]EAC. A control 
without carbodiimide was subjected to the same procedure and 
used for subsequent analyses. The enzyme solutions from the 
column were immediately diluted and assayed six times for en- 
zyme activity, twice each for three separate dilutions, and 
triplicate 20041 aliquots of each modified thrombin solution 
were added to 5 ml Ecolume scintillation fluid and counted on 
a Beckman LS-1OOC scintillation counter. Finally, the UV- 
visible spectrum of each thrombin solution was run on a Perkin- 
Elmer Lambda 6 spectrophotometer to determine the enzyme 
concentration. 
3. RESULTS AND DISCUSSION 
It has previously been shown [2] that bovine 
thrombin is inactivated in a second order process 
by both EDC and EAC. Human thrombin shows 
similar inactivation kinetics. In 50 mM MES, pH 
6.0, at 25”C, inactivation of the human enzyme by 
5, 10, 20, or 40 mM EDC is characterized by half- 
times for inactivation of 69, 36, 23, and 9.2 min, 
respectively (data not shown). When modification 
was carried out with 5, 10, 20, or 40 mM EAC 
under otherwise identical conditions, the half-times 
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for inactivation were found to be 25, 13, 5.1, and 
3.6 min, respectively (data not shown). 
Fig.1 shows the effect of pH on k ‘, the pseudo- 
first-order rate constant for inactivation of human 
thrombin by 20 mM ECD. The plot strongly sug- 
gests that inactivation is critically dependent on a 
protonated carboxyl group with a pZG of 5.6, in ex- 
cellent agreement with earlier data [2] which sug- 
gest that the essential carboxyl in bovine thrombin 
modified by EDC has a pK, of 5.5. 
DAPA, a blocked arginine derivative, is a potent 
competitive inhibitor of thrombin. At pH 8, it has 
a kinetic Ki of approximately 0.1 ,BM [l 11, al- 
though it may have a lower affinity for thrombin 
under more acidic conditions (R.L. Lundblad, per- 
sonal communication). Since DAPA is a simple 
arginine derivative, it likely binds to thrombin with 
its positively charged guanidinium moiety exten- 
ding into the substrate specificity pocket where it 
electrostatically interacts with Asp-189. 
PH 
Fig. 1. Effect of pH on the rate of inactivation of human throm- 
bin by EDC. Thrombin (60yg/ml) was treated at 25°C with 
20 mM EDC in 75 mM Mes, 25 mM Hepes, at the pH in- 
dicated. At various times aliquots were withdrawn and assayed 
for residual thrombin activity as described in the text. A plot of 
the logarithm of the residual activity vs time was linear at each 
pH, and this plot was used to determine k’, the pseudo-first- 
order rate constant for inactivation. The figure shows the rela- 
tionship between k ’ and pH. The data points are given in closed 
circles, while the solid line represents the results of a least-square 
analysis. The best fit to the data is given by a pKa of 5.6, k ‘min = 
0 min-‘, and k’,,,,, = 0.151 min-‘. 
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Fig.2. Effect of DAPA on the rate of inactivation of human 
thrombin by EDC. Thrombin (6Ocgfml) was treated at 25’C 
with 40 mM EDC in 75 mM Mes, 25 mM Hepes, pH 6.0, in the 
presence of the following concentrations of DAPA: (o) 44 pM; 
(0) 15 .uM; (A) 4.4rM; (m) 1.5 pM; or (0) none. At various 
times aliquots were assayed for residual thrombin activity as 
described in the text, and the values of k ‘, the pseudo-first-order 
rate constant for inactivation, were determined from these data. 
Separate controls were run for each modification to compensate 
for the potent inhibitory effect of even low concentrations of 
DAPA in the thrombin assay. 
The rate of inactivation of human thrombin by 
40 mM EDC at pH 6.0 is reduced in the presence of 
DAPA (fig.2), with increasing protection as the 
concentration of inhibitor is increased. However, it 
appears that even when the enzyme approaches 
saturation with DAPA, inactivation proceeds at a 
significant rate. For example, the pseudo-first 
order rate constant for inactivation by 40 mM 
EDC at pH 6.0 and 25°C in the presence of 1.5 PM 
DAPA is only 47% of that in the absence of 
DAPA, but this value is decreased only to 17% of 
the control value when [DAPA] is increased 
30-fold. 
Fig.3A shows a Dixon plot (l/k bbs vs [DAPA]) 
of the data derived from the experiment shown in 
fig.2. If the binding of DAPA provided complete 
protection against inactivation, the plot in fig.3A 
would be linear. It is obvious that thrombin 
saturated with DAPA is still inactivated at a signifi- 
cant rate. When the data shown in fig.3A are cor- 
rected for k iim, the rate of inactivation when the 
enzyme is saturated with DAPA, the data shown in 
Fig.3. Dixon plots of the data derived from the experiment 
PAPAI, PM 
606- 
[DAPAI, PM 
shown in fig.2. (A) The plot of l/k ‘& vs [DAPA) is nonlinear, 
suggesting that even when thrombin is saturated with DAPA, 
inactivation by EDC proceeds at a significant rate. (l3) The k bbS 
at each concentration of DAPA was corrected for kii,,,, the 
p~udo-first~rder rate constant for inactivation by EDC when 
thrombin is saturated with DAPA. k’tr,,, was determined by 
least-square analysis to give the best linear fit to the modified 
Dixon plot (I/(k &I,$ -k't& vs [DAPAIJ. The best fit straight 
line, given for k ii,,, = 0.0105 min-‘, was determined to be: y = 
11.3x + 24.7, from which K50 for DAPA was calculated to be 
2.19 fiM. 
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Fig.4. 
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EAC/THROMBIN 
Correlation of inactivation of human thrombin with in- 
corporation of [‘%]EAC. See text for details. 
fig.3B are obtained. The best value of k ‘iim was 
determined to be 0.0105 min-‘, or 21% of the 
estimated k ’ for the free enzyme in the absence of 
this competitive inhibitor. KSO for DAPA was 
estimated to be 2.2 PM from the data in fig.3B. Re- 
examination of data previously reported for the in- 
activation of bovine thrombin by EDC in the 
presence of DAPA (fig.4 in [2]) shows that this en- 
zyme behaves in a very similar fashion. The k ‘lim 
for the bovine enzyme was estimated to be 18% of 
estimated k ’ in the absence of DAPA, while &O 
was calculated to be 3.0/cM (data not shown). A 
possible explanation of these data is that if indeed 
DAPA binds to thrombin to shield Asp-189, the 
carboxyl group modified by water-soluble carbodi- 
imides is one other than Asp-189. Likely can- 
didates might be Glu-192, Glu-97, and Asp-221, 
which are not carboxyl residues in trypsin and 
which have been proposed to form a cluster of 3 
negative charges around the catalytic triad of 
thrombin [IO]. Other interpretations of the data 
shown in figs 2 and 3 are possible. 
In the absence of added amine nucleophiles, the 
most likely end product of carboxyl modification 
by a carbodiimide is an N-acylurea [9,12,13]. In- 
deed it has been found that amine nucleophiles are 
not necessary for the inactivation of bovine throm- 
bin by EDC, and in fact significantly reduce the 
rate of inactivation [2]. When the loss of human 
thrombin activity is correlated with the stoichio- 
metry of [14C]EAC incorporation, full inactivation 
corresponds to the modification of approximately 
2.5-3 carboxyls per enzyme molecule (fig.4). 
Human mu-thrombin has 35 carboxyl groups per 
molecule [5,14], so the selectivity of carboxyl 
mo~fication by EAC is quite high. Further work 
needs to be done to determine which carboxyl 
groups are modified by EAC to decide the role of 
the essential carboxyl group(s) in thrombin 
catalytic activity. 
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